Eckardt L, Breithardt G, Haverkamp W (2002) Electrophysiologic characterization of the antipsychotic drug sertindole in a rabbit heart model of torsade de pointes: low torsadogenic potential despite QT-prolongation. J Pharmacol Exp Ther 300: 64-71 Wichter T, Matheja P, Eckardt L, Kies P, Schäfers K, Kirchhof P, Schulze-Bahr E, Haverkamp W, Borggrefe M, Schober O, Breithardt G, Schäfers M (2002) Cardiac autonomic dysfunction in Brugada syndrome assessment of presynaptic norepinephrine reuptake with the use of 123I-MIBG SPECT. Circulation 12: 702-06 Bruns H-J, Eckardt L, Vahlhaus C, Haverkamp W, Borggrefe M, Breithardt G, Wichter T (2002) Body surface potential mapping in patients with Brugada syndrome: Right precordial ST segment variations and reverse changes in left precordial leads. Cardiovasc Res 54: 58-66 Wittkampf F, Loh P, Derksen R, Simmers TA, Eckardt L (2002) Real-time, three-dimensional, nonfluoroscopic localization of the Lasso catheter. J Cardiovasc Electrophysiol 13: 630 Eckardt L, Breithardt G, Haverkamp W (2002) Idiopathic left ventricular tachycardia localized at the distal end of the posterior fascicle by non-contact activation mapping. Heart 87: 374 Eckardt L, Kirchhof P, Schulze-Bahr E, Loh P, Rolf S, Ribbing M, Bruns HJ, Witte A, Milberg P, Borggrefe M, Breithardt G, Wichter T, Haverkamp W (2002) Electrophysiologic investigation in Brugada syndrome: Yield of programmed ventricular stimulation at two ventricular sites with up to three premature beats. Eur Heart J 23: 1394-1401 Kirchhof P, Loh P, Eckardt L, Ribbing M, Rolf S, Eick O, Wittkampf F, Borggrefe M, Breithardt G, Haverkamp W (2002) A non-fluoroscopic catheter visualization system (LocaLisa) reduces radiation exposure during catheter ablation of supraventricular tachycardias. Am J Cardiol 90: 340-434 Junker J, Haverkamp W, Schulze-Bahr E, Eckardt L, Paulus W, Kiefer R (2002) Amiodarone and acetazolamide for the treatment of genetically confirmed severe Andersen syndrome. Neurology 59: 466 Eckardt L, Bruns HJ, Paul Matthias, Kirchhof P, Schulze-Bahr E, Wichter T, Breithardt G, Borggrefe M, Haverkamp W (2002) Body surface area of ST-elevation and the presence of late potentials correlate to the inducibility of ventricular tachyarrhythmias in Brugada syndrome. J Cardiovasc Electrophysiol 13: 742-49 Smits JPP, Eckardt L, Probst V, Bezzina CR, Schott JJ, Remme CA, Haverkamp W, Breithardt G, Escande D, Schulze-Bahr E, LeMarec H, Wilde A (2002)  Genotype-phenotype relationship: electrocardiographic features differentiate SCN5A-related patients from non-SCN5A-related patients. J Am Coll Cardiol 40: 350-56 Eckardt L (2002) Corornary sinus automaticity, J Cardiovasc Electrophysiol13: 288-289 Mönnig G, Schulze-Bahr E, Wedekind H, Eckardt L, Kirchhof P, Funke H, Kotthoff S, Vogt J, Assmann G, Breithardt G, Haverkamp W (2002) Genetik und Klinik des Jervell und Lange-Nielsen Syndroms, Z Kardiol: 91:380-388 Eckardt L, Rolf S, Mönnig G, Bruns HJ, Schulze-Bahr E, Milberg P, Kirchhof P, Wichter T, Borggrefe M, Breithardt G, Haverkamp W, (2002) Klinik und Therapie des Brugada Syndroms, Herzschrittmacher und Elektrophysiologie: 13, 157-165 Eckardt L, Haverkamp W, Breithardt G (2002) Antiarrhythmic therapy in heart failure, Heart Failure Monitor: 2: 110-119 Haverkamp W, Ammer R, Kirchhof P, Eckardt L, Fabritz L, Breithardt G (2002) Vorhofflimmern: Molekularbiologische Grundlagen, Herz 27:301-305 Wichter T, Schuze-Bahr E, Eckardt L, Paul M, Levkau B, Meyerborg M, Schäfers M, Haverkamp W, Breithardt G (2002), Molecular mechanisms of inherited ventriucular arrhythmias, Herz; 27: 712-739 Wasmer K, Eckardt L, Böcker D (2002) The autonomic nervous system and cardiac arrhythmias] Internist; 43: 1079-84